关于在单一欧洲中心应用常规病理学对透明细胞肾细胞癌的梅奥诊所分期、大小、分级和坏死（SSIGN）评分进行外部验证的编辑评论 - Suppr | 超能文献

Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.

作者信息

Blute Michael L

出版信息

Eur Urol. 2010 Jan;57(1):110-1. doi: 10.1016/j.eururo.2008.11.035. Epub 2008 Nov 28.

DOI:10.1016/j.eururo.2008.11.035

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.关于在单一欧洲中心应用常规病理学对透明细胞肾细胞癌的梅奥诊所分期、大小、分级和坏死（SSIGN）评分进行外部验证的编辑评论

Eur Urol. 2010 Jan;57(1):110-1. doi: 10.1016/j.eururo.2008.11.035. Epub 2008 Nov 28.

2

Editorial comment on: External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.关于在单一欧洲中心应用常规病理学对透明细胞肾细胞癌的梅奥诊所分期、大小、分级及坏死（SSIGN）评分进行外部验证的编辑评论

Eur Urol. 2010 Jan;57(1):109-10. doi: 10.1016/j.eururo.2008.11.034. Epub 2008 Nov 28.

3

External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.在一家欧洲中心，通过常规病理学方法对 Mayo 临床分期、大小、分级和坏死（SSIGN）评分在透明细胞肾细胞癌中的应用进行外部验证。

Eur Urol. 2010 Jan;57(1):102-9. doi: 10.1016/j.eururo.2008.11.033. Epub 2008 Nov 28.

4

External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.梅奥诊所肾癌特异性生存评分在日本透明细胞肾细胞癌系列中的外部验证

J Urol. 2008 Oct;180(4):1290-5; discussion 1295-6. doi: 10.1016/j.juro.2008.06.014. Epub 2008 Aug 15.

5

External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma.使用欧洲一系列传统肾细胞癌病例对梅奥诊所分期、大小、分级和坏死（SSIGN）评分进行外部验证，以预测癌症特异性生存率。

J Urol. 2006 Apr;175(4):1235-9. doi: 10.1016/S0022-5347(05)00684-1.

6

High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.存活素蛋白的高表达水平可独立预测接受透明细胞肾细胞癌手术患者的不良预后。

Cancer. 2006 Jul 1;107(1):37-45. doi: 10.1002/cncr.21952.

7

The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.在多变量环境中，pNx/pN0分组对透明细胞肾细胞癌患者预后建模的影响。

J Urol. 2002 Jul;168(1):56-60.

8

The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma.在预测透明细胞肾细胞癌患者的癌症特异性生存率方面，“分期、大小、分级和坏死”评分比加利福尼亚大学洛杉矶分校综合分期系统更为准确。

BJU Int. 2009 Jan;103(2):165-70. doi: 10.1111/j.1464-410X.2008.07901.x. Epub 2008 Sep 8.

9

Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.肾周脂肪浸润和肿瘤大小在肾细胞癌中的预后意义

J Urol. 2008 Aug;180(2):486-91; discussion 491. doi: 10.1016/j.juro.2008.04.034. Epub 2008 Jun 11.

10

The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.非遗传性肾细胞癌的双侧性、病理特征及手术结果的影响

J Urol. 2003 Apr;169(4):1276-81. doi: 10.1097/01.ju.0000051883.41237.43.

引用本文的文献

1

A clinical prediction model for predicting the risk of liver metastasis from renal cell carcinoma based on machine learning.基于机器学习的肾细胞癌肝转移风险预测的临床预测模型。

Front Endocrinol (Lausanne). 2023 Jan 5;13:1083569. doi: 10.3389/fendo.2022.1083569. eCollection 2022.